Skip to main content
. 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547

Figure 1.

Figure 1

Kaplan–Meier estimations of the 6-month and 1-year probabilities of progression-free survival for the per-protocol population (n = 240).